freezing semaglutide compound Compounded Tirzepatide Program: Results, Timeline & Comparison FDA issues warning about some

Case Rep Neurol Med 2013:e809151

Compounded medications are prepared under state and federal compounding regulations but have not undergone the same FDA approval process as finished products

Insulin Syringes (U-100) Use 1 mL syringes for higher tirzepatide doses (15 mg = 150 units at 10 mg/mL)

(2015) described the development of angiotensin IV analogs including Dihexa and their HGF/c-Met potentiation mechanism (PMID: 25455861) Expression of Concern: The landmark 2012 paper describing Dihexa's cognitive effects received an expression of concern from the journal (PMID: 34551989), citing data integrity issues including questioned Western blot images Retraction: A follow-up paper from the same research group was retracted (PMID: 40312093), further undermining the evidence base for Dihexa's reported effects No Human Studies: No clinical trials, pharmacokinetic studies, or safety assessments have been conducted in humans Limited Independent Replication: The core claims about Dihexa's cognitive-enhancing effects have not been independently replicated by groups outside the original laboratory The Evidence Gap: This comparison starkly illustrates the difference between a compound with decades of clinical validation (Cerebrolysin) and one with provocative preclinical data undermined by integrity concerns (Dihexa)

You can purchase semaglutide or tirzepatide online through InjectCo after completing a virtual evaluation